IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.716
AS - Asia 3.772
SA - Sud America 2.189
EU - Europa 1.986
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 14.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.594
BR - Brasile 1.916
SG - Singapore 1.371
CN - Cina 1.162
UA - Ucraina 690
VN - Vietnam 360
HK - Hong Kong 301
DE - Germania 291
IT - Italia 258
FR - Francia 180
SE - Svezia 148
TR - Turchia 123
FI - Finlandia 120
AR - Argentina 111
GB - Regno Unito 97
IN - India 72
BD - Bangladesh 71
IQ - Iraq 60
ZA - Sudafrica 45
CA - Canada 43
EC - Ecuador 40
RU - Federazione Russa 39
MX - Messico 36
UZ - Uzbekistan 34
BE - Belgio 31
MA - Marocco 31
CO - Colombia 30
VE - Venezuela 30
JP - Giappone 27
ID - Indonesia 24
KE - Kenya 24
PK - Pakistan 24
PL - Polonia 20
KR - Corea 19
JO - Giordania 17
PY - Paraguay 17
CL - Cile 16
ES - Italia 16
TN - Tunisia 15
AT - Austria 13
AU - Australia 13
CZ - Repubblica Ceca 13
PE - Perù 12
DO - Repubblica Dominicana 11
NL - Olanda 11
RO - Romania 10
UY - Uruguay 10
AL - Albania 9
KZ - Kazakistan 9
OM - Oman 9
DZ - Algeria 8
EU - Europa 8
IR - Iran 8
NP - Nepal 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
EG - Egitto 6
SA - Arabia Saudita 6
BH - Bahrain 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
CR - Costa Rica 4
KG - Kirghizistan 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
LT - Lituania 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
BN - Brunei Darussalam 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
Totale 14.815
Salva come PNG Salva come JPEG
Città #
Dallas 2.762
Chandler 675
Singapore 672
Jacksonville 420
San Jose 383
Hong Kong 292
Ashburn 286
Princeton 238
Beijing 229
Dearborn 216
Nanjing 192
Ho Chi Minh City 134
New York 122
Lauterbourg 119
São Paulo 112
Ann Arbor 109
Wilmington 106
Hanoi 84
Shanghai 81
Izmir 76
Rio de Janeiro 73
Los Angeles 68
Sassari 64
Nanchang 57
Shenyang 56
Belo Horizonte 53
Woodbridge 46
Santa Clara 45
Brasília 44
Hebei 43
Tianjin 42
Changsha 39
Baghdad 31
Jiaxing 31
Tashkent 31
Brussels 30
Guarulhos 27
Johannesburg 27
Rome 27
Tokyo 26
Porto Alegre 24
Curitiba 23
Boardman 22
Buffalo 22
Kunming 22
Nairobi 22
Council Bluffs 21
Helsinki 21
Montreal 20
Santo André 20
Andover 19
Buenos Aires 19
Ningbo 19
Seoul 19
Campinas 18
Caxias do Sul 18
Guangzhou 18
Jinan 18
Orem 18
Sorocaba 18
Amman 17
Columbus 17
Denver 17
Ribeirão Preto 17
San Francisco 17
San Mateo 17
Warsaw 17
Da Nang 16
Frankfurt am Main 16
Hangzhou 16
Istanbul 16
Mountain View 16
Munich 16
Norwalk 16
The Dalles 16
Guayaquil 15
Houston 15
Quito 15
Toronto 15
Haiphong 14
Bogotá 13
Brooklyn 13
Contagem 13
Dhaka 13
Fortaleza 13
Goiânia 13
London 13
Salvador 13
Zhengzhou 13
Asunción 12
Casablanca 12
Manaus 12
Mumbai 12
Osasco 12
Recife 12
Stockholm 12
São José do Rio Preto 12
Taizhou 12
Chennai 11
Chicago 11
Totale 9.137
Salva come PNG Salva come JPEG
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 458
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 284
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 247
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 240
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 234
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 207
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 187
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 178
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 173
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 167
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 160
Composti farmaceutici 158
Approcci terapeutici contro il cancro. Tradizione e innovazione. 156
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 153
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 148
Antiviral activity of benzotriazole based derivatives 145
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 144
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 144
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 144
Oxadiazoles having antiproliferative activity 142
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 140
A survey of Recent Patents on CB2 Agonists in the Management of Pain 138
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 137
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 136
CAPITOLO 41. Antielmintici 136
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 135
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 135
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 133
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 131
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 130
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 129
Pharmaceutical compounds 128
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 128
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 127
Chimica farmaceutica 126
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 126
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 123
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 122
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 120
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 120
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 117
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 116
The organic chemistry of drug design and drug action 116
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 116
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 116
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 116
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 115
Pharmaceutical Compounds 115
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 115
Diazacyclic compounds having affinity for opioid receptors 114
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 114
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 112
Synthesis of biologically active bridged diazabicycloheptanes 111
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 111
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 110
Oxadiazoles having anti proliferative activity 110
Pharmaceutical Compounds 109
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 109
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 109
Pharmaceutical compounds 107
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 106
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 105
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 103
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 102
Novel diazabicycloalkane delta opioid agonists 102
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 102
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 102
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 102
Pharmaceutical compounds 101
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 101
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 101
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 101
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 100
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 100
Pharmaceutical compounds 100
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 98
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 97
Chimica farmaceutica. Con e-book 97
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 96
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 95
Pharmaceutical compounds 95
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 94
Pharmaceutical compounds 94
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 93
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 93
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 91
Ossadiazoli ad attività antiproliferativa 91
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 91
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 90
Pharmaceutical compounds 89
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 89
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 89
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 88
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 88
Pirazoli Triciclichi. Sintesi e valutazione biologica di ligandi per i recettori cannabinoidi con struttura diidroindenopirazolica contenente differenti sostituenti carbossamidici 87
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 87
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 87
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 87
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 86
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 85
Totale 12.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 135 82 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.579 20 20 186 59 124 117 277 583 1.351 573 161 108
2025/20266.254 222 1.544 1.679 875 387 312 669 146 248 172 0 0
Totale 14.961